When analyzing both forms of GSK3β expression in specific astrocytoma types, diffuse astrocytoma revealed 50% (5/10) of the samples with a lack or low levels of pGSK3β-S9 expression, while 70% (7/10) of the samples showed high levels of pGSK3β-Y216. This evidence concerns the gene GSK3B and diffuse astrocytoma.